Mkts

TherapeuticsMD, Inc.

NASDAQ: TXMD
$1.79+0.01 (+0.56%)
As of Oct 28, 4:00 PM ET

Key statistics

Day range
1.751.82
52-week range
1.112.95
Today
Open1.77
Previous close1.79
Volume119.7K
Valuation
Market cap20.58M
P/E ratio—
EPS (TTM)-0.02
Income & risk
Dividend / yield—
Beta0.65
Avg volume25.4K
Discussion

TXMD News

Stories mentioning TXMD from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue724.00393.00
Cost of Goods Sold
Gross Profit0.000.000.000.00
Operating Expenses
Research & Development
Sales General & Admin1,5511,0811,582
Total Operating Expenses1,4472,4451,6461,6471,6741,7141,6813,023
Operating Income (Loss)(723.00)(1,552)(862.00)(695.00)(1,281)(1,047)(1,134)(2,789)
Interest Income41.0029.00
Interest Expense
Other Expense
Pretax Income103.00(580.00)50.00545.00(668.00)83.00(567.00)(1,050)
Tax Provision(32.00)
Net Income (Loss)95.00(619.00)152.00551.00(653.00)252.00(609.00)(1,090)
Earnings Per Share (Basic)0.01(0.05)0.010.05(0.06)0.02(0.05)(0.09)
Earnings Per Share (Diluted)0.01(0.05)0.010.05(0.06)0.02(0.05)(0.09)
Weighted Average Shares Outstanding (Basic)12.0011,56911,57411,57412.0011,53211,53211,532
Weighted Average Shares Outstanding (Diluted)12.0011,56911,57411,57412.0011,53211,53211,532

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About TXMD

TherapeuticsMD, Inc. (NASDAQ: TXMD) is a stock listed on the Nasdaq Stock Market under the ticker symbol TXMD. It last traded at $1.79 (Oct 28, 2026, 4:00 PM ET), up 0.6% on the day. That gives TherapeuticsMD a market capitalisation of $20.6M.

Over the past 52 weeks TXMD has traded between $1.11 and $2.95.

Revenue for the quarter ended Mar 31, 2026 was $724.0K; net income $95.0K. Revenue was up 84.2% from $393.0K in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$724.0K$95.0K13.1%
Dec 31, 2025—-$619.0K—
Sep 30, 2025—$152.0K—
Jun 30, 2025—$551.0K—

From TherapeuticsMD’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…